Multi Vessel Coronary Artery Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multi Vessel Coronary Artery Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Multi Vessel Coronary Artery Disease trials you may qualify forThis study aims to examine the correlation between Fractional Flow Reserve (FFR) FFR Computed Tomography (CT) and invasive FFR in a real-world setting using ret…
The prospective study will investigate the clinical performance and long-term safety of scaffold implantation in a real world regional setting. The protocol inc…
The goal of this study is to investigate the equivalence in early and long-term efficacy between the two "Leave nothing behind strategies" (Drug-Coated Baloon \…
Many patients with non-ST-segment elevation myocardial infarction (NSTEMI) have multivessel coronary artery disease (MVD), which is associated with poor clinica…
The objective of this Phase 1b trial is to evaluate the safety and tolerability of procizumab, a monoclonal antibody under development for the treatment of card…
The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arteri…
CARTIZ is a prospective observational clinical registry of adults in Mexico receiving tirzepatide (a dual GLP-1/GIP receptor agonist) under an independent clini…
The objective of this study is to evaluate the safety and feasibility of Minimally Invasive Coronary Artery Bypass surgery in selected patients ,with multi vess…